Page last updated: 2024-11-03

probenecid and Bronchiectasis

probenecid has been researched along with Bronchiectasis in 1 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Bronchiectasis: Persistent abnormal dilatation of the bronchi.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allen, MB1
Fitzpatrick, RW1
Barratt, A1
Cole, RB1

Trials

1 trial available for probenecid and Bronchiectasis

ArticleYear
The use of probenecid to increase the serum amoxycillin levels in patients with bronchiectasis.
    Respiratory medicine, 1990, Volume: 84, Issue:2

    Topics: Adult; Aged; Amoxicillin; Bronchiectasis; Drug Administration Schedule; Drug Therapy, Combination; F

1990
chemdatabank.com